Nerve growth factor expression response to induction agent booster dosing in transfected human embryonic kidney cells

Plastic and Reconstructive Surgery

Volumn 115, Issue 2, 2005, Pages 506-514

  McConnell, Michael P ^b   Dhar, Sanjay ^b   Nguyen, Thang ^b   Naran, Sanjay ^b   Calvert, Jay W ^b   Sundine, Michael J ^b   Bradshaw, Ralph A ^b   Evans, Gregory R D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; PONASTERONE A;

ARTICLE; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HEK293; CONTROLLED STUDY; CULTURE MEDIUM; DRUG ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; NGF GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SUPERNATANT; TISSUE ENGINEERING;

CELL DIFFERENTIATION; CELL LINE; CELLS, CULTURED; ECDYSTERONE; HUMANS; KIDNEY; NERVE GROWTH FACTOR; TRANSFECTION;

EID: 14044272230     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.PRS.0000148414.29593.AF     Document Type: Article

References (19)

1. Patrick, C. W., Jr., Zheng, B., Schmidt, M., et al. Dermal fibroblasts genetically engineered to release nerve growth factor. Ann. Plast. Surg. 47: 660, 2001.
2. Jimenez, J. C., Tyson, D. R., Dhar, S., et al. Human embryonic kidney cells (HEK-293): Characterization and dose response for modulated release of NGF for nerve regeneration. Plast. Reconstr. Surg. 113: 605, 2004.
3. Raffioni, S., Zhu, Y. Z., Bradshaw, R. A., and Thompson, L. M. Effect of transmembrane and kinase domain mutations on fibroblast growth factor receptor 3 chimera signaling in PC-12 cells: A model for the control of receptor tyrosine kinase activation. J. Biol. Chem. 273: 35250, 1998.
4. Patrick, C. W., Jr., Zheng, B., Wu, X., et al. Muristerone A-induced nerve growth factor release from genetically engineered human dermal fibroblasts for peripheral nerve tissue engineering. Tissue Eng. 7: 303, 2001.
5. Doupe, A. J., Landis, S. C., and Patterson, P. H. Environmental influences in the development of neural crest derivatives: Glucocorticoids, growth factors, and chromaffin cell plasticity. J. Neurosci. 5: 2119, 1985.
6. Tischler, A. S., and Greene, L. A. Phenotypic plasticity of pheochromocytoma and normal adrenal medullary cells. Adv. Biochem. Psychopharmacol. 25: 61, 1980.
7. Millesi, H. The nerve gap: Theory and clinical practice. Hand Clin. 2: 651, 1987.
8. Liu, H. M., Lei, H. Y., and Kao, K. P. Correlation between NGF levels in wound chamber fluid and cytological localization of NGF and NGF receptor in axotomized rat sciatic nerve. Exp. Neurol. 132: 24, 1995.
9. Everill, B., and Kocsis, J. D. Nerve growth factor maintains potassium conductance after nerve injury in adult cutaneous afferent dorsal root ganglion neurons. Neuroscience 100: 417, 2000.
10. Rahimi, O., and Juliano, S. L. Transplants of NGF secreting fibroblasts restore stimulus-evoked activity in barrel cortex of basal-forebrain-lesioned rats. J. Neurophysiol. 86: 2081, 2000.
11. Shoemaker, S. E., Kudwa, A. E., and Isaacson, L. G. Sympathetic ingrowth to the trigeminal ganglion following intracerebroventricular infusion of nerve growth factor. Brain Res. 956: 136, 2002.
12. Pagnotta, A., Tos, P., Fornaro, M., et al. Neurotrophins and their receptors in early axonal regeneration along muscle-vein-combined grafts. Microsurgery 22: 300, 2002.
13. Menderes, A., Yilmaz, M., Vayvada, H., et al. Effects of nerve growth factor on the neurotization of denervated muscles. Ann. Plast. Surg. 48: 415, 2002.
14. Skaper, S. D. Nerve growth factor: A neurokine orchestrating neuroimmune-endocrine functions. Mol. Neurobiol. 24: 183, 2001.
15. Dekker, A. J., Winkler, J., Ray, J., et al. Grafting of nerve growth factor-producing fibroblasts reduces behavioral deficits in rats with lesions of the nucleus basalis magnocellularis. Neuroscience 60: 299, 1994.
16. Dekker, A. J., Fagan, A. M., Gage, F. H., and Thai, L. J. Effects of brain-derived neurotrophic factor and nerve growth factor on remaining neurons in the lesioned nucleus basalis magnocellularis. Brain Res. 639: 149, 1994.
17. Dekker, A. J., Gage, F. H., and Thai, L. J. Delayed treatment with nerve growth factor improves acquisition of a spatial task in rats with lesions of the nucleus basalis magnocellularis: Evaluation of the involvement of different neurotransmitter systems. Neuroscience 48: 111, 1992.
18. Allen, S. J., Robertson, A. G. S., Tyler, S. J., et al. Recombinant human nerve growth factor for clinical trials: Protein expression, purification, stability and characterization of binding to infusion pumps. J. Biochem. Biophys. Methods 47: 239, 2001.
19. McConnell, M. P., Dhar, S., Naran, S., et al. In vivo induction and delivery of nerve growth factor using HEK-293 cells. Tissue Eng. 10: 1492, 2004.